Trueblood Wealth Management LLC Has $811,000 Stock Position in Danaher Co. (NYSE:DHR)

Trueblood Wealth Management LLC boosted its stake in Danaher Co. (NYSE:DHR) by 4.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,532 shares of the conglomerate’s stock after purchasing an additional 150 shares during the quarter. Trueblood Wealth Management LLC’s holdings in Danaher were worth $811,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Coronation Fund Managers Ltd. raised its position in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its position in shares of Danaher by 14.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 10,260 shares of the conglomerate’s stock worth $2,563,000 after buying an additional 1,321 shares during the last quarter. Bridges Investment Management Inc. acquired a new stake in Danaher in the second quarter valued at about $240,000. AE Wealth Management LLC grew its position in Danaher by 10.8% in the second quarter. AE Wealth Management LLC now owns 15,619 shares of the conglomerate’s stock valued at $3,903,000 after acquiring an additional 1,518 shares during the last quarter. Finally, Legacy Financial Advisors Inc. raised its stake in Danaher by 5.2% during the second quarter. Legacy Financial Advisors Inc. now owns 2,585 shares of the conglomerate’s stock worth $646,000 after acquiring an additional 127 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the topic of several research reports. Raymond James decreased their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Scotiabank began coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. TD Cowen raised their price objective on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Trading Down 1.4 %

Shares of DHR stock opened at $238.41 on Monday. The company has a market cap of $172.20 billion, a P/E ratio of 45.50, a PEG ratio of 4.23 and a beta of 0.83. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The stock has a 50 day simple moving average of $234.85 and a two-hundred day simple moving average of $253.42. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.02 EPS. Research analysts forecast that Danaher Co. will post 7.49 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.